Olivia Kramer
Primary Care · Hamburg, MINPI 1619508991
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $631 and has fallen 97.5% since, to $16 in 2025.
Across 86 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$228
- AstraZeneca$180
- Novartis$168
- Merck$100
- Boehringer Ingelheim$85
- Lilly USA, LLC$62
- plus $630 from 20 others
What the payments were for
- Food & beverage$1,454100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $228 |
| AstraZeneca | 10 | $180 |
| Novartis | 10 | $168 |
| Merck | 5 | $100 |
| Boehringer Ingelheim | 6 | $85 |
| Lilly USA, LLC | 4 | $62 |
| GSK | 4 | $59 |
| Astellas Pharma US Inc | 4 | $59 |
| Novo Nordisk | 4 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Bayer | 3 | $51 |
| Johnson & Johnson | 2 | $47 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Amgen | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Amarin Pharma, Inc. | 2 | $26 |
| Eisai Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Pfizer | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Covis Pharma GmbH | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$1,454 in reported general payments places this provider in the 75th percentile of 292 primary care providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $10,435 |
| Levothyroxine Sodium | 66 | $691 |
| Bupropion XlBupropion Hcl | 11 | $461 |
| Losartan Potassium | 33 | $394 |
| Sertraline Hcl | 25 | $333 |
| Atorvastatin Calcium | 34 | $318 |
| Rosuvastatin Calcium | 20 | $317 |
| Omeprazole | 18 | $281 |
| Lisinopril | 39 | $280 |
| Amlodipine Besylate | 33 | $274 |
| Montelukast Sodium | 13 | $271 |
| Gabapentin | 18 | $239 |
| Metoprolol Succinate | 13 | $219 |
| Alendronate Sodium | 13 | $132 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $127 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $58 | $10,43511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 292 primary care providers in Michigan.
Other primary care in Hamburg
- Donna HamillGrosse Pointe$17K
- Marie Sighe-NzokouLansing$16K
- Alexandria SchwabBay City$10K
- Amy HenryRochester Hills$10K
- Claire GebaraWaterford$9K
- Vanita RobinsonDetroit$9K
- Mary BoudreauMason$9K
- Kimberly FrazierLansing$8K
- Rachel HetznerMadison Heights$8K
- Katherine HouleMarquette$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.